Page last updated: 2024-09-05

sorafenib and dihydroceramide

sorafenib has been researched along with dihydroceramide in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (dihydroceramide)	Trials (dihydroceramide)	Recent Studies (post-2010) (dihydroceramide)
6,520	730	5,251	159	2	88

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Beyer, S; Grammatikos, G; Jakobi, K; Koch, A; Pfeilschifter, J; Schwalm, S; Thomas, D; Zeuzem, S	1

Other Studies

1 other study(ies) available for sorafenib and dihydroceramide

Article	Year
Sorafenib Treatment and Modulation of the Sphingolipid Pathway Affect Proliferation and Viability of Hepatocellular Carcinoma In Vitro. International journal of molecular sciences, 2020, Mar-31, Volume: 21, Issue:7 Topics: Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ceramides; Hep G2 Cells; Humans; Liver Neoplasms; Protein Kinase Inhibitors; Sorafenib; Sphingolipids	2020

Article

Year

Sorafenib Treatment and Modulation of the Sphingolipid Pathway Affect Proliferation and Viability of Hepatocellular Carcinoma In Vitro.

International journal of molecular sciences, 2020, Mar-31, Volume: 21, Issue:7

Topics: Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ceramides; Hep G2 Cells; Humans; Liver Neoplasms; Protein Kinase Inhibitors; Sorafenib; Sphingolipids

2020